ATXN2 Gene Spinocerebellar Ataxia Type 2 Autosomal Dominant Genetic Test sale cost 4400 AED
MYOT Gene Spheroid Body Myopathy Genetic Test sale cost 4400 AED MYOT Gene Spheroid Body Myopathy Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
ATXN7 Gene Spinocerebellar Ataxia Type 7 Autosomal Dominant Genetic Test sale cost 4400 AED ATXN7 Gene Spinocerebellar Ataxia Type 7 Autosomal Dominant Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ATXN2 Gene Spinocerebellar Ataxia Type 2 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ATXN2 gene spinocerebellar ataxia type 2 (SCA2) autosomal dominant genetic test is a specialized diagnostic procedure aimed at identifying mutations in the ATXN2 gene, which are known to cause spinocerebellar ataxia type 2. This condition is a neurodegenerative disorder characterized by progressive coordination problems, difficulty walking, and other neurological symptoms due to degeneration of the cerebellum and its connections. Since SCA2 is inherited in an autosomal dominant manner, having just one copy of the altered gene is sufficient to cause the disorder.

The test is crucial for individuals with a family history of SCA2 or those exhibiting symptoms suggestive of the condition. Early detection through genetic testing can aid in the management of symptoms, genetic counseling, and informing family planning decisions. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect mutations in the ATXN2 gene.

DNA Labs UAE offers this genetic test, providing a comprehensive analysis for those at risk of or suspected to have spinocerebellar ataxia type 2. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. Conducted in a state-of-the-art facility, the test adheres to high standards of quality and confidentiality, ensuring reliable and secure results for patients and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ATXN2 Gene Spinocerebellar ataxia type 2 autosomal dominant Genetic Test

Components: ATXN2 Gene Spinocerebellar ataxia type 2 autosomal dominant Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ATXN2 Gene Spinocerebellar ataxia type 2, autosomal dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ATXN2 Gene Spinocerebellar ataxia type 2, autosomal dominant.

Test Details

ATXN2 gene Spinocerebellar ataxia type 2 (SCA2) is a rare genetic disorder characterized by progressive degeneration of the cerebellum, leading to impaired coordination and balance. It is an autosomal dominant disorder, which means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of SCA2, NGS testing can identify mutations or variations in the ATXN2 gene that are associated with the condition.

The NGS genetic test for SCA2 typically involves obtaining a blood or saliva sample from the individual suspected of having the condition. The sample is then sent to a laboratory where DNA is extracted and sequenced using NGS technology. The sequencing data is then analyzed to identify any mutations or variations in the ATXN2 gene that may be causing SCA2.

NGS genetic testing for SCA2 can provide valuable information for diagnosis, prognosis, and genetic counseling. It can help confirm a suspected diagnosis of SCA2, especially in cases where symptoms are unclear or overlap with other conditions. It can also provide information about the specific genetic mutation present in an individual, which can be useful for predicting the severity and progression of the disease.

Additionally, NGS testing can help identify individuals who are at risk of developing SCA2 but do not yet show symptoms. This information can be important for family planning and making informed decisions about reproductive options.

It is important to note that NGS genetic testing for SCA2, like any other genetic test, has limitations. It may not detect all possible mutations or variations in the ATXN2 gene, and a negative test result does not completely rule out the possibility of having SCA2. Therefore, genetic testing should be interpreted in conjunction with clinical evaluation and other diagnostic tests. Genetic counseling is recommended before and after NGS testing to help individuals understand the implications of the test results and make informed decisions about their healthcare.

Test Name ATXN2 Gene Spinocerebellar ataxia type 2 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ATXN2 Gene Spinocerebellar ataxia type 2, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATXN2 Gene Spinocerebellar ataxia type 2, autosomal dominant
Test Details

ATXN2 gene Spinocerebellar ataxia type 2 (SCA2) is a rare genetic disorder characterized by progressive degeneration of the cerebellum, leading to impaired coordination and balance. It is an autosomal dominant disorder, which means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of SCA2, NGS testing can identify mutations or variations in the ATXN2 gene that are associated with the condition.

The NGS genetic test for SCA2 typically involves obtaining a blood or saliva sample from the individual suspected of having the condition. The sample is then sent to a laboratory where DNA is extracted and sequenced using NGS technology. The sequencing data is then analyzed to identify any mutations or variations in the ATXN2 gene that may be causing SCA2.

NGS genetic testing for SCA2 can provide valuable information for diagnosis, prognosis, and genetic counseling. It can help confirm a suspected diagnosis of SCA2, especially in cases where symptoms are unclear or overlap with other conditions. It can also provide information about the specific genetic mutation present in an individual, which can be useful for predicting the severity and progression of the disease.

Additionally, NGS testing can help identify individuals who are at risk of developing SCA2 but do not yet show symptoms. This information can be important for family planning and making informed decisions about reproductive options.

It is important to note that NGS genetic testing for SCA2, like any other genetic test, has limitations. It may not detect all possible mutations or variations in the ATXN2 gene, and a negative test result does not completely rule out the possibility of having SCA2. Therefore, genetic testing should be interpreted in conjunction with clinical evaluation and other diagnostic tests.

Genetic counseling is recommended before and after NGS testing to help individuals understand the implications of the test results and make informed decisions about their healthcare.

SKU: TEST-2064 Category:

Related products